Bank of The Ozarks boosted its stake in shares of Danaher Corporation (NYSE:DHR) by 15.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,782 shares of the conglomerate’s stock after buying an additional 787 shares during the period. Bank of The Ozarks’ holdings in Danaher Corporation were worth $494,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the stock. Norges Bank bought a new stake in shares of Danaher Corporation during the fourth quarter worth about $465,363,000. Dodge & Cox bought a new stake in shares of Danaher Corporation during the fourth quarter worth about $406,424,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new stake in shares of Danaher Corporation during the fourth quarter worth about $90,178,000. Parnassus Investments CA increased its stake in shares of Danaher Corporation by 15.3% in the first quarter. Parnassus Investments CA now owns 8,622,528 shares of the conglomerate’s stock worth $712,738,000 after buying an additional 1,143,284 shares in the last quarter. Finally, American Century Companies Inc. increased its stake in shares of Danaher Corporation by 108.5% in the first quarter. American Century Companies Inc. now owns 1,928,414 shares of the conglomerate’s stock worth $164,937,000 after buying an additional 1,003,306 shares in the last quarter. 76.56% of the stock is currently owned by institutional investors.

Danaher Corporation (NYSE DHR) traded down 1.42% on Tuesday, hitting $80.27. 2,995,784 shares of the stock were exchanged. The company has a 50-day moving average of $83.66 and a 200 day moving average of $84.23. The firm has a market cap of $55.76 billion, a P/E ratio of 25.62 and a beta of 1.03. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01.

Danaher Corporation (NYSE:DHR) last announced its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company’s revenue was up 6.3% on a year-over-year basis. During the same period last year, the firm earned $0.90 EPS. Equities research analysts expect that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This story was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.thecerbatgem.com/2017/08/08/danaher-corporation-nysedhr-shares-bought-by-bank-of-the-ozarks-updated-updated-updated.html.

A number of brokerages recently issued reports on DHR. Wells Fargo & Company reissued a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Jefferies Group LLC reiterated a “buy” rating and issued a $95.00 price target on shares of Danaher Corporation in a research note on Friday. BidaskClub cut Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 25th. Credit Suisse Group reaffirmed a “buy” rating and set a $93.00 target price on shares of Danaher Corporation in a research report on Wednesday, May 24th. Finally, Janney Montgomery Scott lowered Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $91.76.

In related news, SVP Angela S. Lalor sold 10,815 shares of the firm’s stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the completion of the transaction, the senior vice president now directly owns 39,020 shares of the company’s stock, valued at $3,283,923.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider William King sold 7,458 shares of the firm’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $82.97, for a total transaction of $618,790.26. Following the transaction, the insider now directly owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The disclosure for this sale can be found here. Insiders have sold a total of 38,623 shares of company stock worth $3,206,426 over the last 90 days. Insiders own 12.20% of the company’s stock.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.